111 related articles for article (PubMed ID: 12960129)
1. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma.
Ding Y; Shimada Y; Maeda M; Kawabe A; Kaganoi J; Komoto I; Hashimoto Y; Miyake M; Hashida H; Imamura M
Clin Cancer Res; 2003 Aug; 9(9):3406-12. PubMed ID: 12960129
[TBL] [Abstract][Full Text] [Related]
2. CCR7 affects the tumor microenvironment by regulating the activation of naïve CD8
Yan C; Du W; Kirkwood KL; Wang Y; Zhou W; Li Z; Tian Y; Lin S; Zheng L; Al-Aroomi MA; Gao J; Jiang S; Sun C; Liu F
Transl Oncol; 2024 Jun; 44():101924. PubMed ID: 38430712
[TBL] [Abstract][Full Text] [Related]
3. CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer.
Yang S; Dong D; Bao X; Lu R; Cheng P; Zhu S; Yang G
Cancer Control; 2024; 31():10732748241238616. PubMed ID: 38553809
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory properties of the lymphatic endothelium in the tumor microenvironment.
Viúdez-Pareja C; Kreft E; García-Caballero M
Front Immunol; 2023; 14():1235812. PubMed ID: 37744339
[TBL] [Abstract][Full Text] [Related]
6. Endogenous CCL21-Ser deficiency reduces B16-F10 melanoma growth by enhanced antitumor immunity.
Fujie R; Kurowarabe K; Yamada Y; Fujiwara K; Nakatani H; Tsutsumi K; Hayashi R; Kawahata H; Miyamoto M; Ozawa M; Katakai T; Takahama Y; Ohigashi I; Hayasaka H
Heliyon; 2023 Aug; 9(8):e19215. PubMed ID: 37664721
[TBL] [Abstract][Full Text] [Related]
7. Nonclassical monocytes potentiate anti-tumoral CD8
Padgett LE; Marcovecchio PM; Olingy CE; Araujo DJ; Steel K; Dinh HQ; Alimadadi A; Zhu YP; Meyer MA; Kiosses WB; Thomas GD; Hedrick CC
Front Immunol; 2023; 14():1101497. PubMed ID: 37426658
[TBL] [Abstract][Full Text] [Related]
8. CCL21-Ser expression in melanoma cells recruits CCR7
Miyamoto M; Kawato Y; Fujie R; Kurowarabe K; Fujiwara K; Nobusawa R; Hayashi R; Iida K; Ohigashi I; Hayasaka H
Cancer Sci; 2023 Sep; 114(9):3509-3522. PubMed ID: 37421165
[TBL] [Abstract][Full Text] [Related]
9. Connecting the Dots: The Cerebral Lymphatic System as a Bridge Between the Central Nervous System and Peripheral System in Health and Disease.
Zhao H; Sun M; Zhang Y; Kong W; Fan L; Wang K; Xu Q; Chen B; Dong J; Shi Y; Wang Z; Wang S; Zhuang X; Li Q; Lin F; Yao X; Zhang W; Kong C; Zhang R; Feng D; Zhao X
Aging Dis; 2024 Feb; 15(1):115-152. PubMed ID: 37307828
[TBL] [Abstract][Full Text] [Related]
10. Identification and verification of immune-related gene prognostic signature based on ssGSEA for breast cancer.
Chen G; Cao J; Zhao H; Cong Y; Qiao G
Cent Eur J Immunol; 2022; 47(2):139-150. PubMed ID: 36751391
[TBL] [Abstract][Full Text] [Related]
11. C-C Chemokine Receptor 7 in Cancer.
Bill CA; Allen CM; Vines CM
Cells; 2022 Feb; 11(4):. PubMed ID: 35203305
[TBL] [Abstract][Full Text] [Related]
12. Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis.
Shokati Eshkiki Z; Khayer N; Talebi A; Karbalaei R; Akbari A
BMC Med Genomics; 2022 Feb; 15(1):30. PubMed ID: 35180880
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.
Hayasaka H; Yoshida J; Kuroda Y; Nishiguchi A; Matsusaki M; Kishimoto K; Nishimura H; Okada M; Shimomura Y; Kobayashi D; Shimazu Y; Taya Y; Akashi M; Miyasaka M
Cancer Sci; 2022 Apr; 113(4):1338-1351. PubMed ID: 35133060
[TBL] [Abstract][Full Text] [Related]
14. Expression and functional analysis of chemokine receptor 7 in canine lymphoma cell lines.
Kanei T; Iwata M; Kamishina H; Mizuno T; Maeda S
J Vet Med Sci; 2022 Jan; 84(1):25-30. PubMed ID: 34866095
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging Radiotracers of Chemokine Receptors.
Alluri SR; Higashi Y; Kil KE
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500609
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
[TBL] [Abstract][Full Text] [Related]
17. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
Korbecki J; Grochans S; Gutowska I; Barczak K; Baranowska-Bosiacka I
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076281
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Epstein-Barr virus nuclear antigen 1 favor Tregs accumulation in nasopharyngeal carcinoma.
Wang J; Luo Y; Bi P; Lu J; Wang F; Liu X; Zhang B; Li X
Cancer Med; 2020 Aug; 9(15):5598-5608. PubMed ID: 32573058
[TBL] [Abstract][Full Text] [Related]
19. The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.
Rizeq B; Malki MI
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32340161
[TBL] [Abstract][Full Text] [Related]
20. Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy.
Jones D
Cells; 2020 Mar; 9(3):. PubMed ID: 32244922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
